Advocacy Actions

2019-09-25 > Beijing

Comments to the NMPA's Notice on Matters Related to the First Batch of Implementation of the Unique Device Identification of Medical Devices (Call for Comment)

On 25th September, the medical devices sector submitted comments to the National Medical Products Administration on the Notice on Matters Related to the First Batch of Implementation of the Unique Device Identification of Medical Devices (Call for Comment).

Read more
2019-09-24 > Beijing

COCIR and HCE Members Contribute the 10th China International Medical Device Regulatory(CIMDR) Forum in Suzhou

As the co-supporter of the 10th China International Medical Device Regulatory (CIMDR) Forum in Suzhou, COCIR and several members of the Healthcare Equipment Working Groups attended the conference as the moderator and speaker for plenary and sub-forums.

Read more
2019-09-23 > Beijing

Meeting with the Centre for Medical Device Evaluation of the National Medical Product Administration on the Regulations on Random Inspection of Medical Devices Quality (Draft for Comments)

On 23rd September. the Centre for Medical Device Evaluation of the National Medical Products Administration held a meeting on Regulations on Random Inspection of Medical Devices Quality (Draft for Comments).

Read more
2019-09-20 > Beijing

Comments to the NMPA's Regulations on Expansive Clinical Trial of Medical Devices

On 20th September, the medical devices sector submitted comments to the National Medical Products Administration on the Regulations on Expansive Clinical Trial of Medical Devices.

Read more
2019-09-20 > Beijing

Advocacy Letter to the State Administration for Market Regulation on Procurement Issue in Guangxi Province

On 20th September, the medical device sector sent an advocacy letter to the Antitrust Office of the State Administration for Market Regulation on procurement issue in Guangxi province.

Read more
2019-09-18 > Beijing

DITTA Chair Met with the Deputy Commissioner of NMPA

On 18th September, DITTA Chair met with the Deputy Commissioner of National Medical Products Administration.

Read more
2019-09-17 > Beijing

Comments to the SAMR's Interim Measures for Handling Complaints and Reporting in Market Supervision and Administration (Draft for Comments)

On 17th September, the Chamber submitted comments to the State Administration for Market Regulation on the Interim Measures for Handling Complaints and Reporting in Market Supervision and Administration (Draft for Comments).

Read more
2019-09-12 > Beijing

Comments to the National Medical Products Administration on the Regulations on Random Inspection of Medical Devices Quality

On 27 August 2019, the Department of Comprehensive Affairs from National Medical Products Administration (NMPA) has initiated public consultations on Regulations on Random Inspection of Medical Devices Quality.

Read more
2019-09-12 > Beijing

Comments to the NMPA's Public Consultation on the Regulations on Random Inspection of Medical Devices Quality (Draft for Comments)

On 12th September, the medical device sector submitted comments to the National Medical Products Administration on the Regulations on Random Inspection of Medical Devices Quality (Draft for Comments).

Read more
2019-09-02 > Beijing

update the procurement issue from medical equipment sector to the EU Delegation

update the procurement issue from medical equipment sector to the EU Delegation

Read more